Designated “Best of Nursing Homes 2019-2020 - Highest Performing Short-Term Stay” by U.S. News and World Report (Bloomingdale, Chicago Ridge, Elmhurst, La Grange, Lake Zurich, Lombard, Schaumburg) Designated “Best of Nursing Homes 2020” by Newsweek (Bloomingdale) Winner of McKnight`s Long-Term Care News Excellence in Technology "2017 Gold Innovator of the Year" for Curatess Telemedicine Platform Awarded "Best"/Top Performer by U.S. News and World Report: Lexington Health Care Center of Elmhurst Lexington Health Network is Chicagoland`s premier provider of post-acute care & rehabilitation, long-term care, memory care, independent & assisted living, home health care, hospice care and private duty nursing. As the leader of integrated health services, Lexington Health Network is with you, from hospital to home and beyond. Today, Lexington Health Network manages more than 2,000 skilled nursing beds in 10 different post hospital, nursing and long term care buildings as well as more than 500 independent retirement units and more than 150 assisted living units within 3 senior living centers. Our diverse network of health care services also offers home health care, hospice care and private care services. Lexington proudly employs more than 2,500 full and part time individuals enabling us to provide an immeasurable value to the communities we serve. So much of who we are comes from an integrated organization dedicated to the highest attainable quality of care available today. As a family-owned organization, we have always maintained a unique perspective. Whether you are a post-acute patient, resident, a family member, or an employee, you are considered an extension of our family. In an industry filled with rapid change and growth, the Lexington constant, of our commitment to family values, will never change. Welcome to the Lexington Health Network.
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
Precedence is a Rock Island, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Isoflux Biomed is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Babeskin Bodycare is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.